Loyola University Medical Center
Bone Marrow Transplant Program
Building 112, Room D29
2160 South First Avenue
Maywood, IL 60153
Direct phone: (708) 327-3216
Total transplants by cell source
- Marrow: 30
- PBSC: 51
- Cord Blood: 21
- Autologous (PBSC or Marrow): 122
About the center
Formed in 1996, LUMC is a FACT-accredited transplant program affiliated with the SWOG clinical trials. We provide a multidisciplinary team approach to related, unrelated and auto transplants for adults with a variety of hematologic/solid tumor diseases. We offer CAR T cellular therapy using an FDA approved product and an in-house clinical trial.
This center has been performing allogeneic transplants since 1986 and has been an NMDP/Be The Match transplant center since December 1996.
Adult - Patrick Hagen, Charles Hemenway, Nasheed Hossain, Scott Smith, Patrick J. Stiff, Stephanie Tsai
Pediatric - Charles Hemenway
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Other programs and services
Our Bone Marrow Transplant and Cellular Therapy Program is a comprehensive adult program that is FACT accredited for both autologous and allogeneic transplants. We have discounted housing available within a few miles of campus through our nearby hotels. Our patients receive personalized care throughout the BMT process with a dedicated team of BMT physicians, Advanced Practice Providers (APPs) and a specifically assigned Transplant Nurse Coordinators. Our care team also includes BMT-specific RNs, Social Workers, Nutritionists, Clinical Pharmacist, Psychologists, and Physical Therapists.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are below the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2017, 2018, 2019, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 130 patients.
The actual 1-year survival of these patients is 63.5%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 64.9% and 79.4%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2019 to December 31st, 2020 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2019 to December 31st, 2020 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
Transplant center coordinator:
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)